Untitled - Response by van Tulder, M.W. et al.
VU Research Portal
Untitled - Response
van Tulder, M.W.; Bouter, L.M.; Koes, B.W.
published in
Spine
1998
DOI (link to publisher)
10.1097/00007632-199806010-00025
document version
Publisher's PDF, also known as Version of record
Link to publication in VU Research Portal
citation for published version (APA)
van Tulder, M. W., Bouter, L. M., & Koes, B. W. (1998). Untitled - Response. Spine, 23(11), 1290-1291.
https://doi.org/10.1097/00007632-199806010-00025
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
E-mail address:
vuresearchportal.ub@vu.nl
Download date: 13. Dec. 2021
SPINE Volume 23, Number 11, pp 1288-1291
01998, Lippincott—Raven Publishers
Letters
To the Editor:
The recent work of van Tulder et al" represents an im-
pressive volume of literature summarized in one meta-
analysis. For students of conservative spine care, the evo-
lution and steadfast focus of the group from the
Netherlands is obvious. Although this reader is biased,
generally in favor of the conclusions they have reached,
there is reason to be concerned about the care, consis-
tency, and accuracy with which the group has applied
their own criteria for methodologic assessment. Obvi-
ously, in a meta-analysis, the veracity of the treatment
effects being considered do not change. What changes
from one meta-analysis to another is the perspective
from which the original research studies are evaluated.
The science of meta-analysis alternatively may be consid-
ered hypothesis testing for the differences in criteria used
to include and rank studies. Similarly apparent is that the
processes of rating studies are only as good as the con-
sistency by which they are applied.
The recent work headed by van Tulder is one that
appears to have grown to its current mass through a
sequence of efforts and earlier publications. The authors,
however, indicate in Table 1 that, "The operationaliza-
tion of the criteria has been published in our previous
systematic review [references 42-45 cited]." Those ref-
erences, however, are the works of Evans et a1, 5 Faas
Chavannes et a1, 6 Faas Van Eijk et a1, 7 and Farrel and
Twomey.8
Over the past decade it has been interesting to observe
the development of this group's struggle with the litera-
ture on back pain. Unfortunately, earlier publications12
and the mistakes made in applying the methodologic cri-
teria have been carried forward again into this publica-
tion. We take specific issue with the incorrect assignment
of methodologic criteria scores for the work published
by Triano et al." Of the 17 criteria reported by van
Tulder et al,' 3 we dispute the consistency of application
in six. Table 1 lists the disputed criteria and the ranking
that was given.
Table 2 quotes or, for longer sections, paraphrases the
relevant sections from Triano et a1, 11 which, we submit,
support our contention that the methodologic criteria
were applied incorrectly.
In the case of criterion D, there seems to be little ex-
planation for a rating of 0 out of 3. As an author, one is
Table 1. Criteria and Scores
Criteria List
	
Scores
Study population
D. Drop-outs described for each study group separately
	
0 of 3
Interventions
G. Interventions standardized and described
	
5 of 10
I. Co-interventions avoided
	
0 of 5
Effect
Patients blinded
	
2 of 5
Outcome measures relevant
	
4 of 10
M. Blinded outcome assessment
	
0 of 10
always concerned with how to be clear in communicat-
ing methods and results. It is difficult to conceive of a
better way to account for "Drop-outs described for each
study group separately" (Criterion G) than to list them
explicitly by group. No other report on manipulation
published before 1995 has been as detailed in describing
the interventions than our report. The descriptions re-
quired nearly one full page, and were referenced to stan-
dard teaching texts.' Moreover, the manual methods
(high velocity low force and high velocity low amplitude)
were quantified through biomechanical and biologic
quality control measures, randomly, throughout the
course of the study. Results confirming the stability of
these procedures were reported in the text. Co-
interventions (Criterion I) and any unblinding (Criterion
K) were identified in an exit interview, in which subjects
who believed they had not received legitimate treatment
were isolated and removed from the data analysis. The
outcome measures focused on the standard measures of
pain, function, and psychological status, excluding only
patient satisfaction (Criteria L). These measures were
and are the categories that are considered relevant to
back pain treatment studies.2-4' 1 ° In fact, they are con-
sidered important categories of outcome by the Agency
for Health Care and Policy Research, 2 which was the
foundation for the "levels of evidence criteria" used by
van Tulder 12 in his original work. Because our popula-
tion was ambulatory and still working, more aggressive
functional outcome such as return-to-work was irrele-
vant. Finally, one might argue that the inclusion of the
methodologist on teams 2 and 5 would create an un-
blinding of analysis. However, it is clear that such in-
volvement would not allow access to the treatment and
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Table 2. Evidence From Triano et al (1995)
Criterion	 Evidence of Incorrect Application
Page 951: From all three treatment groups, only 18.7% (7
HVLA; 14 HVLF; 18 BEP) elected to drop out of the
study before completion." The n size for each separate
group and variable after removing confounding factors
from the exit interview were given explicitly in the ta-
bles reported by the study.
Page 949-50: The HVLA, HVLF mimic, and BEP treatments
were described in detail and referenced, where appro-
priate, to standard teaching texts for the procedures
(HVLA). Standardization of treatment was similarly
made with respect to frequency of provider contact
with the patient and time spent with the patient across
all three treatment groups.
Page 950: "Quality control measures were put in place to
independently verify the performance of the HVLA and
HVLF on a random basis." Quality control measures
were biomechanical and biologic, with descriptions
given and references from detail of previous work pro-
vided. "This quality control showed the modifications of
the HVLF to be highly successful and further biologic
testing was discontinued after 8 months." Figure 2
(page 951) further quantified the differences between
the HVLA and HVLF experimental treatments that were
administered.
I, K	 Page 951: "During the debriefing interview on completion
of the study protocol for each participant, 25 patients
were identified who had serious confounding factors.
Types of confounding factors included unblinding of the
participant, new trauma occurring during the interven-
ing time between accepting the patient into the study
and protocol completion, and cointerventions capable
of altering results on study outcome measures. Data
from these subjects were eliminated from analysis"
L	 Page 950: "Three primary outcome measures designed to
evaluate perceived pain, functional activity, and limited
emotional status were selected on the basis of a feasi-
bility study 38, which confirmed the findings of Deyo 15
regarding their reliability and validity within our patient
population."
M	 Page 949: "Every effort was made to ensure that investi-
gators were masked, by establishing separate evalua-
tion and treatment teams that were rigorously segre-
gated in terms of duties and familiarity with patient
information. Patient screeing for candidacy was carried
out by team 1. Recruitment, primary outcome mea-
sures, and administration of the randomized treatment
assignment tables were the responsibility of team 2.
Secondary outcomes measures were obtained by team
3. Treatment was administered. By team 4 according to
random assignment. Finally, data analysis was carried
out at the end of the study by team 5, which consisted
of the principal investigator and project methodologist.
No information crossed team boundaries with the ex-
ception of the methodologist who participated on
teams 2 and 5."
outcome measures that were obtained by other teams.
Moreover, a presumption of bias further presumes that
an individual investigator is capable of retaining the de-
tails of 209 separate patients interviewed over a period of
several months or that such an investigator would de-
code data intentionally in an effort to bias it.
The problems and cautions related to meta-analysis
have been described previously by other authors. 9 There
is no good way to determine what can constitute the
correct criteria; therefore multiple reports, even those
from the same authors, can be published, just by chang-
ing criteria applications. Does this provide any greater
understanding of the issues related to the treatment ef-
fects or does it tend to foster greater confusion? This is a
greater quandary when there is inconsistency in the ap-
plication of the selected criteria.
Granted, all writing is not as successful in communi-
cation as a writer might prefer, but the issues that are
raised in the criteria of van Tulder et a1 13 are addressed
prominently in the manuscript by Triano et al." Even
given different viewpoints on relative merit, it is difficult
to understand how criteria D, G, and M were given no
value by the reviewers. One must ask how the integrity of
this meta-analysis, as a whole, can be presumed if nearly
30% of the criteria judgments made on just one refer-
enced study can be challenged so obviously by a simple
review.
John J. Triano, DC
Texas Back Institute
Plano, Texas
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In Response:
We would like to respond to the letter written by Dr.
John Triano regarding our article' published in Spine.
Dr. Triano's first comment concerns the legend of Ta-
ble 1, in which we refer to our previous reviews using the
wrong references. We are thankful to Dr. Triano for
noticing this, and we admit that this must have escaped
our attention when checking the proofs of the article.
The correct references, however, are given at several
places in the text, for example just below Table 1 on page
2129 in the last sentence of the left column and the first
sentence of the right column, "the same criteria list was
used in our previously published systematic reviews [ref-
erences 78, 79, 84, and 85 cited]."
The most important issue in Dr. Triano's letter is his
concern about the consistency and accuracy of our meth-
odologic quality assessment. Dr. Triano disputes our ap-
plication of six of the methodologic quality criteria to his
randomized clinical trial. However, we believe that the
main problem he has with our application does not relate
to the consistency of the application, but solely concerns
our operationalization of the criteria. We would like to
illustrate this with two examples:
Regarding item D, the drop-out rate, Dr. Triano
states that from all three treatment groups only
18.7% dropped out, and that the corresponding num-
bers were listed explicitly by group. Our operational-
ization of this item was "drop-outs described for each
study group separately and with reason for with-
drawal [references 78, 79, 84, and 85 cited]." In Dr.
Triano's study, only 117 of the 209 randomly selected
subjects are included in the analysis of disability, and
only 129 are included in the analysis of pain. Reasons
for noncompliance with treatment or for missing fol-
low-up measurements can be correlated with treat-
ment results. Therefore, the conclusions of this study
should be interpreted with caution. In our opinion,
Dr. Triano et al have described only some character-
istics of a part of the drop-out group; they certainly
did not describe all drop-outs for each intervention
group with reason for withdrawal. Dr. Triano's study
has been included in several systematic re-
views, 1 '2 '4 '5 ' 7 and has been assessed by various re-
viewers independently from each other. The applica-
tion of this item was very consistent, not only for
reviewers within the same research group or country,
but also for reviewers from other groups and coun-
tries. All reviewers of Triano's randomized clinical
trial scored 0 points for this item!
With regard to the relevance of outcome measures,
item L, Dr. Triano states in his letter that our score of
4 out of 10 possible points is inconsistent. We have
operationalized this item as "the measurement and
report of pain, global measure of improvement, func-
tional status (activities of daily living), spinal mobil-
ity, and medical consumption (2 points each) [refer-
ences 78, 79, 84, and 85 cited]."The three outcome
measures in Dr. Triano's study were pain (visual an-
alog score), functional status (Oswestry), and psycho-
logic depression (modified Zung). Consistent applica-
tion of our operationalization clearly leads to 4
points: 2 for pain and 2 for functional status.
We think that this clarification concerning two of six
disputed criteria is sufficient to make our point: Dr. Tri-
ano did not identify inconsistencies; he simply does not
agree with our operationalization of the criteria. We are
prepared to react in detail to the other four criteria, but
we do not consider this to be very informative to the
readers of Spine.
We are thankful to Dr. Triano for his letter, because it
gives us another opportunity to strongly emphasize that
the methodology of systematic reviews is still in an early
stage of evolution. Within the framework of the Coch-
rane Collaboration, we have been working on the im-
provement of the methodology of systematic reviews,
including the assessment of the methodologic quality.
Just recently in Spine, method guidelines were published
that were developed by the editorial board of the Coch-
rane Back Review Group for Spinal Disorders. 8 These
guidelines aim at improving the quality of systematic
reviews, facilitating comparisons across reviews, and en-
hancing consistency among reviewers.
However, these guidelines are not a "gold standard,"
and do not provide solutions for all methodologic prob-
lems. Some subjective decisions are unavoidable in as-
sessing the quality of a study. We can see three categories
of problems: the choosing and operationalizing of crite-
ria, its consistent application, and the lack of informa-
tion in publications. Regarding the first category, Dr.
Triano's letter shows that there is still plenty room for
discussion. The second category of problems can be
solved in part by using two (or more) reviewers and let-
ting them apply the criteria independently and by using a
consensus method to resolve disagreements, such as we
did in our systematic review. The third category of prob-
lems might be tackled by asking the authors of the orig-
inal studies to provide more information if their reports
are unclear and by asking them if they disagree with any
of our application of criteria. If the authors disagree, they
will be given the opportunity to provide the relevant data
from the analysis or research protocol to convince the
reviewers that they should change their scores. A rele-
vant recent development, the so-called CONSORT state-
ment, consists of recommendations for the report of ran-
domized controlled trials, which have been accepted as a
gold standard by the leading medical journals. 3 In the
near future, we hope to see this and similar initiatives
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being implemented. Clearly this will make further evolu-
tion of systematic reviews possible and will enable the
acceptance of the methods and results of systematic re-
views even by the authors of the randomized clinical
trials being reviewed.
Maurits van Tulder, PhD
Lex Bouter, PhD
Bart Koes, PhD
Institute for Research in Extramural Medicine
Vrije Universiteit Amsterdam
Amsterdam
the Netherlands
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